Enhancing the efficacy of immunity-activating nucleic acid drugs

Aug 23, 2012
Change in efficacy of CpG ODN by use of nanoparticles. (Left) Free CpG ODN molecules induce interleukin 6 (IL-6) by interaction with TLR9. (Center) When CpG ODN is electrostatically bound to silicon nanoparticles (blue circles), induction of interferon (IFN) becomes possible. (Right) When bound only to one end of the silicon nanoparticles, CpG ODN induces IL-6 in the same manner as free CpG ODN.

(Phys.org)—The Nanotechnology Innovation Station of the National Institute for Materials Science has succeeded in development of a technology which utilizes nanoparticles to enhance the action of immunity activating nucleic acid drugs.

Nucleic acid drugs—produced by DNA or RNA—are cutting-edge molecular target drugs that target designated proteins or base sequences with pinpoint accuracy. Nucleic acid drugs are anticipated as potential treatment for cancers, , , and allergic diseases such as pollenosis, etc. In the present research, NIMS succeeded in developing a technology which uses nanoparticles to enhance the efficacy of immunity-activating nucleic acid drugs, with the aim of application to pollenosis and similar diseases.

The nucleic drugs called CpG ODN (cytosine-phosphate-guanine oligodeoxynucleotides), which have already been developed, mainly includes two types. One is the interferon type, which primarily induces interferon. The other is the interleukin type, which induces . Interferon and interleukin 6 are substances that are related to immunostimulation. However, with the conventional method, it was not possible to induce interferon and interleukin 6 simultaneously, even when these two types of CpG ODN were administered simultaneously to increase immune effect.

In the present research, only the interleukin type of CpG ODN was used. This CpG ODN was bound to silicon nanoparticles by two different methods, and the two types of nanoparticles were used simultaneously. As a result, the NIMS researchers succeeded in simultaneously activating and interleukin 6 at a high level for the first time.

The method, in which drugs are applied to medical treatment using nanoparticles as a carrier, is called . In the conventional approach, the main role of the nanoparticles in drug delivery was to deliver the drug to the targeted cells or tissue and release the drug at the affected part. In the present research, the role of the nanoparticles is not limited to the drug transportation and release functions. The nanoparticles also play a critical role in enabling control of manifestation of the effect of the drug.

This achievement will make it possible to apply this drug to treatment of infectious diseases, immunotherapy for cancers, and treatment of pollenosis and other . Application of nucleic acid drugs other than CpG ODN can also be expected.

Explore further: Tough foam from tiny sheets

More information: These research results was published in Scientific Reports, an online journal of British Nature Publishing Group.  

Related Stories

Understanding how cells respond to nanoparticles

Oct 28, 2010

Gold nanoparticles are showing real promise as vehicles for efficiently delivering therapeutic nucleic acids, such as disease-fighting genes and small interfering RNA (siRNA) molecules, to tumors. Now, a team of investigators ...

Gold nanoparticles for controlled drug delivery

Dec 30, 2008

(PhysOrg.com) -- Using tiny gold particles and infrared light, MIT researchers have developed a drug-delivery system that allows multiple drugs to be released in a controlled fashion.

Gold used as safe driver of cancer drug

Mar 21, 2012

(PhysOrg.com) -- Gold nanoparticles can be used as delivery vehicles for platinum anticancer drugs, improving targeting and uptake into cells, according to research published in this month's edition of the ...

Gold Nanoparticles Delivery Platinum Warheads to Tumors

Oct 29, 2009

(PhysOrg.com) -- Cisplatin is one of the most powerful and effective drugs for treating a wide variety of cancers, but serious side effects ultimately limit the drug's use and effectiveness. Now, however, researchers have ...

Recommended for you

Tough foam from tiny sheets

17 hours ago

Tough, ultralight foam of atom-thick sheets can be made to any size and shape through a chemical process invented at Rice University.

Graphene surfaces on photonic racetracks

Jul 28, 2014

In an article published in Optics Express, scientists from The University of Manchester describe how graphene can be wrapped around a silicon wire, or waveguide, and modify the transmission of light through it.

Simulating the invisible

Jul 28, 2014

Panagiotis Grammatikopoulos in the OIST Nanoparticles by Design Unit simulates the interactions of particles that are too small to see, and too complicated to visualize. In order to study the particles' behavior, he uses ...

Building 'invisible' materials with light

Jul 28, 2014

A new method of building materials using light, developed by researchers at the University of Cambridge, could one day enable technologies that are often considered the realm of science fiction, such as invisibility ...

User comments : 0